New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Narasimha Jayanti Prayers: Mahamantra, Katha & Aarti
- Vada Pappu for Narasimha Jayanti – The Sacred No-Cook Moong Dal Prasadam That Asks Almost Nothing of You
- Neer Mor Recipe — The Chilled Spiced Buttermilk That Completes the Narasimha Jayanti Thali
- Phula (2026) Movie Review: A Soulful Tale of Resilience and Folk Art
- Therachaapa Movie Review: A Rooted Rustic Drama Packed With Emotion and Grit
- Salbardi (2026) Review: A Gripping Tale of Mystery and Justice From the Heartland
- Bad Boy Karthik Review (2026): A Brother’s Fight That Packs Enough Heart to Win You Over
- Matka King Review: Vijay Varma’s Finest Hour in a Gripping Bombay Crime Drama